Abstract
Introduction Retention in HIV care is necessary to achieve adherence to antiretroviral therapy, viral load suppression, and optimal health outcomes. There is no standard definition for retention in HIV care, which compromises consistent and reliable reporting and comparison of retention across facilities, jurisdictions, and studies.
Objective The objective of this study is to explore how stakeholders involved in HIV care define retention in HIV care and their preferences on measuring retention.
Methods We will use an exploratory sequential mixed methods design involving HIV stakeholder groups such as people living with HIV, people involved in providing care for PLHIV, and people involved in decision-making about PLHIV. In the qualitative phase of the study, we with conduct 20-25 in-depth interviews to collect perspectives of HIV stakeholders on using their preferred retention measures. The interview guide has being provided as an online Supplementary Appendix 1.The findings from the qualitative phase will inform the development of survey items for the quantitative phase. Survey participants (n=385) will be invited to rate the importance of each approach to measuring retention on a seven-point Likert scale. We will merge the findings from the qualitative and quantitative findings phase to inform a consensus-building framework for a standard definition of retention in care.
Ethical Issues and Dissemination This study has received ethics approval from the Hamilton Integrated Research Ethics Board. The findings will be disseminated through peer-reviewed publications, conference presentations, and among stakeholder groups.
Limitations 1. This study has limitation, we won’t be able to arrive at a standard definition, a Delphi technique amongst the stakeholders will be utilized using the framework to reach a consensus globally accepted definition.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Hamilton Integrated Research Ethics Board has approved this research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
For maintaining the privacy of the participants only deidentified data will be collected, and per HiREB that data won't be shared to maintain the confidentiality of the participants.
